The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa

Gut

Volumn 65, Issue 8, 2016, Pages 1369-1376

  Lemoine, Maud ^a,b   Shimakawa, Yusuke ^b,c   Nayagam, Shevanthi ^a   Khalil, Mustapha ^d   Suso, Penda ^d   Lloyd, Jo ^e   Goldin, Robert ^e   Njai, Harr Freeya ^b   Ndow, Gibril ^b   Taal, Makie ^f   Cooke, Graham ^a   D'Alessandro, Umberto ^b   Vray, Muriel ^c   Mbaye, Papa Saliou ^g   Njie, Ramou ^b   Mallet, Vincent ^h   Thursz, Mark ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^c INSTITUT PASTEUR   (France)

^d Royal Victoria Teaching Hospital Gambia   (Gambia)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f MINISTRY OF HEALTH AND SOCIAL WELFARE   (Gambia)

^g Principal Hospital   (Senegal)

^h UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; BIOLOGICAL MARKER;

ADULT; ARTICLE; ASPARTATE TRANSAMINASE TO PLATELET RATIO INDEX; CHRONIC HEPATITIS B; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIGESTIVE SYSTEM DISEASE ASSESSMENT; ELASTOGRAPH; ELASTOGRAPHY; FEMALE; FIBROSIS 4 SCORE; FRENCHMAN; GAMBIAN; GAMMA GLUTAMYL TRANSPEPTIDASE TO PLATELET RATIO; HEMATOLOGICAL PARAMETERS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENEGALESE; SENSITIVITY AND SPECIFICITY; THROMBOCYTE COUNT; TRANSIENT ELASTOGRAPHY; AFRICA; AREA UNDER THE CURVE; BIOPSY; BLOOD; COMPLICATION; DIMENSIONAL MEASUREMENT ACCURACY; EPIDEMIOLOGY; HEPATITIS B, CHRONIC; LIVER; MIDDLE AGED; PATHOLOGY; PATIENT ACUITY; PROCEDURES; SEVERITY OF ILLNESS INDEX;

ADULT; AFRICA, WESTERN; AREA UNDER CURVE; BIOMARKERS; BIOPSY; DIMENSIONAL MEASUREMENT ACCURACY; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HEPATITIS B, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PATIENT ACUITY; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX;

EID: 84932597596     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2015-309260     Document Type: Article

References (36)

1. Ott JJ, Stevens GA, Groeger J, et al. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 2012;30:2212-19.
2. Parkin DM, Sitas F, Chirenje M, et al. Part I: Cancer in Indigenous Africans-burden, distribution, and trends. Lancet Oncol 2008;9:683-92.
3. Jemal A, Bray F, Forman D, et al. Cancer burden in Africa and opportunities for prevention. Cancer 2012;118:4372-84.
4. Thursz M, Njie R, Lemoine M. Hepatitis: global eradication of hepatitis B-feasible or fallacy? Nat Rev Gastroenterol Hepatol 2012;9:492-4.
5. Castera L. Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology 2012;142:1293-302 e4.
6. Marcellin P, Ziol M, Bedossa P, et al. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int 2009;29:242-7.
7. Degos F, Perez P, Roche B, et al. Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: A multicenter prospective study (the FIBROSTIC study). J Hepatol 2010;53:1013-21.
8. Chan HL, Wong GL, Choi PC, et al. Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. J Viral Hepat 2009;16:36-44.
9. Kim do Y, Kim SU, Ahn SH, et al. Usefulness of FibroScan for detection of early compensated liver cirrhosis in chronic hepatitis B. Dig Dis Sci 2009;54:1758-63.
10. Cardoso AC, Carvalho-Filho RJ, Stern C, et al. Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C. Liver Int 2012;32:612-21.
11. Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38:518-26.
12. Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006;43:1317-25.
13. WHO. World Health Organization. Guidelines for the Prevention, Care and Treatment of Persons with chronic Hepatitis B infection. 2015. http://whoint/hiv/pub/hepatitis/hepatitis-b-guidelines/en/(accessed 17 Mar 2015).
14. Bonnard P, Sombie R, Lescure FX, et al. Comparison of elastography, serum marker scores, and histology for the assessment of liver fibrosis in hepatitis B virus (HBV)-infected patients in Burkina Faso. Am J Trop Med Hyg 2010;82:454-8.
15. Mbaye PS, Sarr A, Sire JM, et al. Liver stiffness measurement and biochemical markers in Senegalese chronic hepatitis B patients with normal ALT and high viral load. PLoS ONE 2011;6:e22291.
16. http://www.prolifica.eu NCT02129829 clinicaltrialsorg. (15 Mar 2015).
17. Mallet V, Dhalluin-Venier V, Roussin C, et al. The accuracy of the FIB-4 index for the diagnosis of mild fibrosis in chronic hepatitis B. Aliment Pharmacol Ther 2009;29:409-15.
18. Njai HF, Shimakawa Y, Sanneh B, et al. Validation of rapid point-of-care (POC) tests for the detection of hepatitis B surface antigen (HBsAg) in field and laboratory settings in The Gambia, West Africa. J Clin Microbiol 2015;53:1156-63.
19. Coco B, Oliveri F, Maina AM, et al. Transient elastography: A new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat 2007;14:360-9.
20. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996;24:289-93.
21. Lemoine M, Shimakawa Y, Njie R, et al. Food intake increases liver stiffness measurements and hampers reliable values in patients with chronic hepatitis B and healthy controls: The PROLIFICA experience in The Gambia. Aliment Pharmacol Ther 2014;39:188-96.
22. Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: A new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003;29:1705-13.
23. Boursier J, Zarski JP, de Ledinghen V, et al. Determination of reliability criteria for liver stiffness evaluation by transient elastography. Hepatology 2013;57:1182-91.
24. Bossuyt PM, Reitsma JB, Bruns DE, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative. Ann Intern Med 2003;138:40-4.
25. Castera L, Foucher J, Bertet J, et al. FibroScan and FibroTest to assess liver fibrosis in HCV with normal aminotransferases. Hepatology 2006;43:373-4; author reply 5-6.
26. Ziol M, Handra-Luca A, Kettaneh A, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005;41:48-54.
27. Castera L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005;128:343-50.
28. Castera L, Bernard PH, Le Bail B, et al. Transient elastography and biomarkers for liver fibrosis assessment and follow-up of inactive hepatitis B carriers. Aliment Pharmacol Ther 2011;33:455-65.
29. Suthar AB, Rutherford GW, Horvath T, et al. Improving antiretroviral therapy scale-up and effectiveness through service integration and decentralization. Aids 2014;28(Suppl 2):S175-85.
30. Shin WG, Park SH, Jang MK, et al. Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B. Dig Liver Dis 2008;40:267-74.
31. Lemoine M, Njai HF, Shimakawa Y, et al. Rural and urban community-based screening for HBs antigen in the Gambia: Assessment of chronic hepatitis B and proportion of eligible patients for antiviral therapy. J Hepatol 2013;58.
32. Myers RP, Tainturier MH, Ratziu V, et al. Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B. J Hepatol 2003;39:222-30.
33. Vardar R, Vardar E, Demiri S, et al. Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis? Hepatogastroenterology 2009;56:1459-65.
34. Eminler AT, Irak K, Ayyildiz T, et al. The relation between liver histopathology and GGT levels in viral hepatitis: more important in hepatitis B. Turk J Gastroenterol 2014;25:411-15.
35. Choi BC. Sensitivity and specificity of a single diagnostic test in the presence of work-up bias. J Clin Epidemiol 1992;45:581-6.
36. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003;38:1449-57.